The Enterprise Value as of September 2024 (TTM) for Rubius Therapeutics, Inc. (RUBY) is -6254911.00

According to Rubius Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6254911.00. This represents a change of -103.65% compared to the average of 171.35M of the last 4 quarters.

Rubius Therapeutics, Inc. (RUBY) Historical Enterprise Value (quarterly & annually)

How has RUBY Enterprise Value performed in the past?

The mean historical Enterprise Value of Rubius Therapeutics, Inc. over the last ten years is 405.51M. The current -6254911.00 Enterprise Value has changed -254.25% with respect to the historical average. Over the past ten years (40 quarters), RUBY's Enterprise Value was at its highest in in the June 2021 quarter at 2.02B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Rubius Therapeutics, Inc. (RUBY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rubius Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rubius Therapeutics, Inc. (RUBY) Average Enterprise Value

How has RUBY Enterprise Value performed in the past?

The current Enterprise Value of Rubius Therapeutics, Inc. (RUBY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rubius Therapeutics, Inc. (RUBY) Enterprise Value vs. Peers

How is RUBY’s Enterprise Value compared to its peers?

Rubius Therapeutics, Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-114170976.00), less than Evelo Biosciences, Inc. (16.69M), greater than AVROBIO, Inc. (-85302404.00), less than Scholar Rock Holding Corporation (636.54M), less than Replimune Group, Inc. (681.29M),

Build a custom stock screener for Rubius Therapeutics, Inc. (RUBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rubius Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rubius Therapeutics, Inc. (RUBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rubius Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.